235 related articles for article (PubMed ID: 32411759)
1. The diagnostic value of the combination of Golgi protein 73, glypican-3 and alpha-fetoprotein in hepatocellular carcinoma: a diagnostic meta-analysis.
Zhao S; Long M; Zhang X; Lei S; Dou W; Hu J; Du X; Liu L
Ann Transl Med; 2020 Apr; 8(8):536. PubMed ID: 32411759
[TBL] [Abstract][Full Text] [Related]
2. Combination of serum alpha-fetoprotein, PIVKA-Ⅱ and glypican-3 in diagnosis of hepatocellular carcinoma: a meta-analysis.
Song H; Wang J; Zhang H; Wu Y; Wang K; Wang X; Xu X
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 53(1):131-139. PubMed ID: 38310085
[TBL] [Abstract][Full Text] [Related]
3. Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis.
Wang Y; Yang H; Xu H; Lu X; Sang X; Zhong S; Huang J; Mao Y
J Gastroenterol Hepatol; 2014 Mar; 29(3):597-602. PubMed ID: 24236824
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis.
Hu B; Tian X; Sun J; Meng X
Int J Mol Sci; 2013 Dec; 14(12):23559-80. PubMed ID: 24317431
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis.
Dai M; Chen X; Liu X; Peng Z; Meng J; Dai S
PLoS One; 2015; 10(10):e0140067. PubMed ID: 26441340
[TBL] [Abstract][Full Text] [Related]
6. Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta-analysis.
Zhou Y; Yin X; Ying J; Zhang B
BMC Cancer; 2012 Jan; 12():17. PubMed ID: 22244200
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of alpha-fetoprotein, lens culinaris agglutinin-reactive alpha-fetoprotein, des-gamma carboxyprothrombin, and glypican-3 for the detection of hepatocellular carcinoma: a systematic review and meta-analysis protocol.
Huang TS; Shyu YC; Turner R; Chen HY; Chen PJ
Syst Rev; 2013 Jun; 2():37. PubMed ID: 23738605
[TBL] [Abstract][Full Text] [Related]
8. A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysis.
Xu C; Yan Z; Zhou L; Wang Y
J Cancer Res Clin Oncol; 2013 Aug; 139(8):1417-24. PubMed ID: 23743582
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of alpha-fetoprotein-L3 and Golgi protein 73 in hepatocellular carcinomas with low AFP levels.
Xu WJ; Guo BL; Han YG; Shi L; Ma WS
Tumour Biol; 2014 Dec; 35(12):12069-74. PubMed ID: 25209179
[TBL] [Abstract][Full Text] [Related]
10. Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.
Xiao J; Long F; Peng T; Hu LB; Cai H; Chen R; Chen WL
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3302-3310. PubMed ID: 31081083
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of α-fetoprotein-L3 and Golgi protein 73 detection in diagnosis of hepatocellular carcinoma.
Jia Z; Wang L; Liu C; Yu Z; Chai L; Zhao M
Contemp Oncol (Pozn); 2014; 18(3):192-6. PubMed ID: 25520580
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy and prognostic significance of Glypican-3 in hepatocellular carcinoma: A systematic review and meta-analysis.
Jiang D; Zhang Y; Wang Y; Xu F; Liang J; Wang W
Front Oncol; 2022; 12():1012418. PubMed ID: 36212469
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of serum dickkopf-1 protein in diagnosis hepatocellular carcinoma: An updated meta-analysis.
Li Z; Mou L; Gao H; Zeng Y; Tang X; Deng X; Pu Z; Ni Y; Zhan Y
Medicine (Baltimore); 2019 Aug; 98(32):e16725. PubMed ID: 31393380
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin versus alpha-fetoprotein as a diagnostic marker for hepatocellular carcinoma: a meta-analysis.
Sun T; Tang Y; Sun D; Bu Q; Li P
Onco Targets Ther; 2018; 11():8925-8935. PubMed ID: 30573979
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity and specificity of Dickkopf-1 protein in serum for diagnosing hepatocellular carcinoma: a meta-analysis.
Zhang J; Zhao Y; Yang Q
Int J Biol Markers; 2014 Dec; 29(4):e403-10. PubMed ID: 24980448
[TBL] [Abstract][Full Text] [Related]
16. Dynamic Changes in Serum Markers and Their Utility in the Early Diagnosis of All Stages of Hepatitis B-Associated Hepatocellular Carcinoma.
Wu M; Liu Z; Li X; Zhang A; Li N
Onco Targets Ther; 2020; 13():827-840. PubMed ID: 32095079
[TBL] [Abstract][Full Text] [Related]
17. Serum GP73 is complementary to AFP and GGT-II for the diagnosis of hepatocellular carcinoma.
Hou SC; Xiao MB; Ni RZ; Ni WK; Jiang F; Li XY; Lu CH; Chen BY
Oncol Lett; 2013 Oct; 6(4):1152-1158. PubMed ID: 24137480
[TBL] [Abstract][Full Text] [Related]
18. Golgi protein 73 as a biomarker for hepatocellular carcinoma: A diagnostic meta-analysis.
Yang J; Li J; Dai W; Wang F; Shen M; Chen K; Cheng P; Zhang Y; Wang C; Zhu R; Zhang H; Zheng Y; Wang J; Xia Y; Lu J; Zhou Y; Guo C
Exp Ther Med; 2015 Apr; 9(4):1413-1420. PubMed ID: 25780444
[TBL] [Abstract][Full Text] [Related]
19. Alpha-fetoprotein-L3 and Golgi protein 73 may serve as candidate biomarkers for diagnosing alpha-fetoprotein-negative hepatocellular carcinoma.
Zhang Z; Zhang Y; Wang Y; Xu L; Xu W
Onco Targets Ther; 2016; 9():123-9. PubMed ID: 26770061
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Accuracy of Serum/Plasma Circular RNAs and the Combination of Circular RNAs and α-Fetoprotein for Detecting Hepatocellular Carcinoma: A Meta-Analysis.
Nie G; Peng D; Li B; Lu J; Cai Y; Xiong X; Cheng N
Front Genet; 2021; 12():722208. PubMed ID: 34659344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
